发明申请
US20070191343A1 4-((4-(2-Azaperhydroepinylethoxy)phenyl)methyl)-3-2(2,4-dichlorophenyl)-7-hydroxychromen-2-one, pharmaceutically acceptable salts thereof and methods of use therewith
审中-公开
4 - （（4-（2-氮杂氢化乙氧基）苯基）甲基）-3-2（2,4-二氯苯基）-7-羟基色烯-2-酮，其药学上可接受的盐及其使用方法
- 专利标题： 4-((4-(2-Azaperhydroepinylethoxy)phenyl)methyl)-3-2(2,4-dichlorophenyl)-7-hydroxychromen-2-one, pharmaceutically acceptable salts thereof and methods of use therewith
- 专利标题（中）： 4 - （（4-（2-氮杂氢化乙氧基）苯基）甲基）-3-2（2,4-二氯苯基）-7-羟基色烯-2-酮，其药学上可接受的盐及其使用方法
-
申请号： US11523376申请日： 2006-09-18
-
公开(公告)号： US20070191343A1公开(公告)日： 2007-08-16
- 发明人: Steven Sakata , Rama Narla , Bernd Stein
- 申请人： Steven Sakata , Rama Narla , Bernd Stein
- 主分类号： A61K31/55
- IPC分类号： A61K31/55 ; C07D409/02
摘要：
This invention relates to Benzopyranone Compounds, compositions comprising a Benzopyranone Compound and methods for treating or preventing cancer or inhibiting the growth of a cancer cell or neoplastic cell comprising administering an effective amount of a Benzopyranone Compound to a patient in need thereof. The Benzopyranone Compounds have the formula: including pharmaceutically acceptable salts thereof, wherein R1 and n are as defined herein.
信息查询
